Science Explorer Interactive view Map
Company · Heidelberg · Germany

Affimed Therapeutics (Germany)

affimed.comROR OpenAlex
Research works
101
▼ 20% vs 2013–17
Citations
2k
19.7 per fractional work
Top-10% rate
23.2%
record average 16.5%
Open access
27%
world 28%

Not ranked overall: Affimed Therapeutics (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.62× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 33.35× its world share, 6 worksImmunology and Micro…Neuroscience: 0.99× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.34× its world share, 0 worksPharmacology, Toxico…Engineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.40× its world share, 0 worksMaterials ScienceMathematics: 0.17× its world share, 0 worksMathematicsHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 2.75× its world share, 9 worksMedicineBusiness, Management and Accounting: 0.05× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.09× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 33.4×. Every wedge is a field page.

Who are the top researchers at Affimed Therapeutics (Germany)?

Ranked on the composite score, Martin Treder and Uwe Reusch lead among researchers whose main affiliation is Affimed Therapeutics (Germany).

  1. 1 Martin Treder Germany · #1,547,150 worldwide 3 citations · 24 works
  2. 2 Uwe Reusch Germany · #1,548,346 worldwide 16 citations · 17 works
All ranked researchers at Affimed Therapeutics (Germany)

Which keywords describe research at Affimed Therapeutics (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer Immunotherapy, Lymphoma and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation32▲ 146×3 topics
  2. Monoclonal Antibodies27▲ 187×3 topics
  3. Therapeutic Antibodies26▲ 200×2 topics
  4. Antibody Engineering24▲ 243×1 topic
  5. Fc Receptors24▲ 243×1 topic
  6. Cancer Immunotherapy23▲ 166×3 topics
  7. Lymphoma22▲ 149×3 topics
  8. Immunotherapy20▲ 30×5 topics
  9. Tumor Regression20▲ 223×2 topics
  10. CAR T Cells18▲ 423×1 topic
  11. Chimeric Antigen Receptor18▲ 423×1 topic
  12. Leukemia18▲ 281×2 topics
  13. Cancer10▲ 6.9×5 topics
  14. NK Cell Recognition8▲ 82×1 topic
  15. Natural Killer Cells8▲ 82×1 topic
  16. Immune System7▲ 21×2 topics
  17. Glycans7▲ 81×1 topic
  18. Mucins7▲ 81×1 topic
  19. PET Imaging6▲ 27×3 topics
  20. Rituximab5▲ 31×2 topics
  21. Innate Immunity4▲ 12×3 topics
  22. Immunity4▲ 12×2 topics
  23. Antigen Presentation4▲ 37×1 topic
  24. Autoimmunity4▲ 18×2 topics
  25. Dendritic Cells4▲ 33×1 topic
  26. Classification4▲ 10×1 topic
  27. Molecular Profiling4▲ 31×1 topic
  28. Angiogenesis4▲ 8.4×5 topics
  29. Tumor Microenvironment4▲ 9.9×5 topics
  30. Biopharmaceuticals3▲ 50×3 topics
  31. Monoclonal Antibody3▲ 49×2 topics
  32. Prognostic Factors3▲ 6.1×5 topics
  33. Foxp33▲ 35×1 topic
  34. Immunogenicity3▲ 49×2 topics
  35. TGF-ß3▲ 15×1 topic
  36. Immune Checkpoint Blockade2▲ 43×1 topic
  37. PD-1 and PD-L12▲ 43×1 topic
  38. Immune Regulation2▲ 17×2 topics
  39. Recombinant Proteins2▲ 43×2 topics
  40. Protein Aggregation2▲ 26×2 topics

Which research topics does Affimed Therapeutics (Germany) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and T-cell and B-cell Immunology.

CAR-T cell therapy resea…4CAR-T cell therapy research: 4 fractional worksImmune Cell Function and Interaction: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksT-cell and B-cell Immunology: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksPhagocytosis and Immune Regulation: 0 fractional works
OncologyImmunologyRadiology, Nuclear Medicine and ImagingPathology and Forensic Medicine1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 4 works
  2. 2 Immune Cell Function and Interaction Immunology 3 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 T-cell and B-cell Immunology Immunology 1 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  8. 8 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  9. 9 HER2/EGFR in Cancer Research Oncology 0 works
  10. 10 Phagocytosis and Immune Regulation Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.3%not open72.7%

World: 28% of research is openly available.

with international co-authors29.3%domestic only70.7%

World: 19% is written across borders.

How has Affimed Therapeutics (Germany)'s research output changed?

Output in 2018–2022 was 20% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.